文献速递妇科生殖医学

早发性手术绝经后的激素替代治疗处方模式

Hormone Replacement Therapy Prescription after Premature Surgical Menopause.
PubMed 文献 · J Minim Invasive Gynecol · 2020-03-13

这项回顾性队列研究纳入了63例≤45岁接受微创子宫切除加输卵管卵巢切除术的患者,评估术后6周内激素替代治疗(HRT)的处方模式。结果显示52%的患者使用了HRT,盆腔痛或子宫内膜异位症及Lynch综合征患者更可能使用HRT,而妇科恶性肿瘤、乳腺癌及BRCA基因突变者使用较少。术前HRT咨询与术后HRT使用相关,未使用HRT者中13.3%采用了非激素替代疗法。

要点

  • 早发性手术绝经患者术后6周HRT使用率为52%。
  • 盆腔痛和Lynch综合征患者更可能使用HRT,妇科/乳腺恶性肿瘤及BRCA突变者较少使用。

核心结论

  • 早发性手术绝经患者术后HRT使用率为52%,术前HRT咨询与术后HRT使用相关。

研究设计与样本

  • 回顾性队列研究,纳入63例≤45岁接受微创子宫切除加输卵管卵巢切除术的患者。

主要发现

  • 术后6周内52%(n=33)的患者使用了HRT。
  • 手术绝经指征包括盆腔痛或子宫内膜异位症(31.7%)、妇科恶性肿瘤(20.6%)、BRCA基因突变(17.4%)、乳腺癌(9.5%)、Lynch综合征(4.8%)及其他(15.8%)。
  • 各指征组HRT使用率:盆腔痛80%、妇科恶性肿瘤25%、BRCA突变45%、乳腺癌33.3%、Lynch综合征66.6%。
  • 围手术期并发症不能预测术后HRT使用;未使用HRT者中13.3%采用了非激素替代疗法。

关键数值与推荐

  • HRT使用率52%(33/63)。
  • 非激素替代疗法使用率:未使用HRT者中13.3%。

临床怎么用

  • 对早发性手术绝经患者应加强术前HRT咨询,以提高术后HRT使用率。
  • 根据手术指征个体化评估HRT使用,尤其关注妇科/乳腺恶性肿瘤及BRCA突变患者。

局限性

  • 回顾性研究设计,样本量较小(63例),可能存在选择偏倚和信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To assess hormone replacement therapy (HRT) prescription pattern in patients undergoing premature surgical menopause on the basis of surgical indication. DESIGN: Retrospective cohort study. SETTING: Academic tertiary care center. PATIENTS: Surgically menopausal patients aged ≤45 years who underwent a minimally invasive hysterectomy with salpingo-oophorectomy. INTERVENTIONS: HRT prescription in the 6-week postoperative period. MEASUREMENTS AND MAIN RESULTS: A total of 63 patients met inclusion criteria. Of these, 52% (n = 33) were prescribed HRT in the 6-week postoperative period. Indications for surgical menopause included pelvic pain or endometriosis (31.7%), gynecologic malignancy (20.6%), BRCA gene mutation (17.4%), breast cancer (9.5%), Lynch syndrome (4.8%), and other (15.8%). In total, 80% of patients with pelvic pain, 25% with gynecologic malignancies, 45% with BRCA gene mutations, 33.3% with breast cancer, and 66.6% with Lynch syndrome used HRT postoperatively. In patients who used HRT postoperatively, 76% were offered preoperative HRT counseling. This is in contrast with those patients who did not use HRT postoperatively, of whom only 33% were offered HRT counseling (p <.001). Perioperative complications were not predictive of HRT use postoperatively. In patients who did not use HRT postoperatively, 13.3% used alternative nonhormonal therapy. CONCLUSION: In patients who underwent premature surgical menopause, 52% used HRT postoperatively. Patients with pelvic pain and Lynch syndrome were more likely to use HRT, whereas those with gynecologic or breast malignancies and BRCA gene mutations were less likely to use HRT. Preoperative HRT counseling was associated with postoperative HRT use.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Garg N, Behbehani S, Kosiorek H, et al. Hormone Replacement Therapy Prescription after Premature Surgical Menopause. J Minim Invasive Gynecol. 2020. PMID: 32173578. doi:10.1016/j.jmig.2020.03.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。